These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13018597)

  • 1. [Effect of the adrenal gland of an urogastrone preparation].
    COSTA E
    Boll Soc Ital Biol Sper; 1952 May; 28(5):1012-3. PubMed ID: 13018597
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of urogastrone (epidermal growth factor) on the intestinal epithelium.
    Goodlad RA; Wilson TJ; Lenton W; Gregory H; McCullagh KG; Wright NA
    Z Gastroenterol Verh; 1988 Apr; 23():171-7. PubMed ID: 2454546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor.
    Gospodarowicz D; Ill CR; Hornsby PJ; Gill GN
    Endocrinology; 1977 Apr; 100(4):1080-9. PubMed ID: 189990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of wound healing by recombinant human urogastrone (epidermal growth factor).
    Franklin TJ; Gregory H; Morris WP
    J Lab Clin Med; 1986 Aug; 108(2):103-8. PubMed ID: 3488358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hypothalamic-pituitary axis in EGF action on maturation of adrenal gland in fetal rhesus monkey in vivo.
    Coulter CL; Read LC; Barry SJ; Tarantal AF; Styne DM
    Pediatr Res; 2001 Aug; 50(2):210-6. PubMed ID: 11477205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
    Hollenberg MD; Muramatsu I; Itoh H; Patel P; Yang SG; Lederis K
    J Pharmacol Exp Ther; 1989 Jan; 248(1):384-90. PubMed ID: 2783610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of human urogastrone on lung phospholipids in fetal rabbits.
    Haigh RM; Hollingsworth M; Micklewright LA; Boyd RD; D'Souza SW
    J Dev Physiol; 1988 Oct; 10(5):433-43. PubMed ID: 3265425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variation of lysozymic power of certain organs following treatment with urogastrone].
    SANGIORGI G
    Boll Soc Ital Biol Sper; 1952 May; 28(5):1018-9. PubMed ID: 13018601
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in urogastrone excretion produced by extirpation of various endocrine glands.
    KAULBERSZ J; PATTERSON TL
    Am J Physiol; 1947 Sep; 150(3):373-80. PubMed ID: 20265831
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidermal growth factor urogastrone: new targets for the ligand and for its receptor.
    Hollenberg MD
    Proc West Pharmacol Soc; 1986; 29():479-82. PubMed ID: 3489947
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of graded intravenous doses of urogastrone on duodenal bicarbonate secretion in conscious rats: evidence of a dose-response pattern.
    Marotta F; Chui DH; Zhong GG; Safran P
    Digestion; 1990; 47(2):88-94. PubMed ID: 2292357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From urogastrone to epidermal growth factor.
    Gregory H
    Proc West Pharmacol Soc; 1986; 29():355-7. PubMed ID: 3489946
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of ACTH on adrenal size in hypophysectomized rats after removal of one adrenal.
    GANONG WF
    Endocrinology; 1954 Jul; 55(1):117-20. PubMed ID: 13173425
    [No Abstract]   [Full Text] [Related]  

  • 14. Enterogastrone and urogastrone in experimental gastric ulcers caused by phenylquinoline carboxylic acid.
    NASO A
    G Ital Chir; 1953 Feb; 9(2):103-24. PubMed ID: 13060709
    [No Abstract]   [Full Text] [Related]  

  • 15. Species variation in the vascular effects of epidermal growth factor-urogastrone.
    Gan BS; Bolt GR; Hollenberg MD; MacCannell KL
    Proc West Pharmacol Soc; 1986; 29():483-4. PubMed ID: 3489948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epidermal growth factor-urogastrone].
    Zhang JF; Guo YS
    Sheng Li Ke Xue Jin Zhan; 1984 Apr; 15(2):151-6. PubMed ID: 6333725
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of largactil on adrenal gland].
    LOSCALZO B
    G Ital Chir; 1956 Apr; 12(4):213-9. PubMed ID: 13344998
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of proliferation of human fetal adrenal cells in vitro.
    Crickard K; Ill CR; Jaffe RB
    J Clin Endocrinol Metab; 1981 Oct; 53(4):790-6. PubMed ID: 6270174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-inhibitory effect of TGF-B on human fetal adrenal cells in primary monolayer culture.
    Riopel L; Branchaud CL; Goodyer CG; Adkar V; Lefebvre Y
    J Cell Physiol; 1989 Aug; 140(2):233-8. PubMed ID: 2545732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parahydroxypropiophenone effects on rat thyroid, adrenal, and pituitary.
    DANOWSKI TS; WIRTH P; BROWN M; HILL GC; FETTERMAN GH
    J Clin Endocrinol Metab; 1952 Nov; 12(11):1454-60. PubMed ID: 12999985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.